New RSV Drug Delivers Promising Results in Alaska's Yukon-Kuskokwim Delta

Alaska Beacon

Dec 2, 2024

Describes the findings of a recent report by the U.S. Centers for Disease Control and Prevention on the use of nirsevimab to treat RSV among infants in rural Alaska. Notes that the drug helped to reduce the severity of illness among babies and young children in the Yukon-Kuskokwim Delta region, which has the highest rate of RSV-related infant hospitalization in the nation. Discusses how inadequate water and wastewater services and overcrowded housing in rural Alaska contribute to disease spread.

American Indian or Alaska Native · Children and youth · Frontier and remote areas · Infectious diseases · Public health · Alaska